Table 2.
Preoperative FNA, intraoperative frozen section, and final histopathology details
| Factors | Numbers (%) |
|---|---|
| Outside FNA diagnosis | |
| Present | 79 (24.3%) |
| Absent | 246 (75.7%) |
| Change in diagnosis (after in-house FNA review) | |
| Yes | 16 (5.5%) |
| No | 63 (19.7%) |
| Not applicable | 246 (74.8%) |
| Preoperative FNA reported by (overall) | |
| Head and neck pathologist | 175 (53.8%) |
| Non-head and neck pathologist | 150 (46.2%) |
| Preoperative FNA report (overall) | |
| Benign | 87 (26.8%) |
| Malignant | 141 (43.4%) |
| Inconclusive | 79 (24.3%) |
| Non-diagnostic | 18 (5.5%) |
| Intraoperative frozen section (for primary diagnosis, including grade) | |
| Done | 131 (40.3%) |
| Not done | 194 (59.7%) |
| Intraoperative frozen section report | |
| Benign | 49 (15.1%) |
| Malignant | 56 (17.2%) |
| Inconclusive/no diagnosis given | 26 (8%) |
| Intraoperative frozen section grading | |
| Low | 9 (2.8%) |
| Intermediate | 2 (0.6%) |
| High | 6 (1.8%) |
| Not reported | 65 (20%) |
| Not applicable (benign) | 49 (15.1%) |
| Intraoperative frozen reported by | |
| Head and neck pathologist | 38 (11.7%) |
| Non-head and neck pathologist | 93 (28.6%) |
| Final histopathology report of primary | |
| Pleomorphic adenoma | 83 (25.5%) |
| Warthin’s tumour | 18 (5.5%) |
| Other benign tumours | 17 (5.2%) |
| Mucoepidermoid carcinoma | 68 (20.9%) |
| Adenoid cystic carcinoma | 28 (8.6%) |
| Adenocarcinoma | 6 (1.8%) |
| Acinic cell carcinoma | 14 (4.3%) |
| Carcinoma ex-pleomorphic adenoma | 23 (7.1%) |
| Salivary duct carcinoma | 18 (5.5%) |
| Squamous cell carcinoma | 8 (2.5%) |
| Mammary analogue secretory carcinoma | 9 (2.8%) |
| Myoepithelial carcinoma | 12 (3.7%) |
| Epithelial–myoepithelial carcinoma | 5 (1.5%) |
| Lymphoma | 4 (1.2%) |
| Lymphoepithelial carcinoma | 5 (1.5%) |
| Other carcinoma | 7 (2.1%) |
| Grade in final report | |
| Low | 39 (12%) |
| Intermediate | 47 (14.5%) |
| High | 73 (22.5%) |
| Not reported | 47 (14.5%) |
| Not applicable | 119 (36.6%) |
| Pathologist reporting final histopathology report | |
| Head and neck pathologists | 135 (41.5%) |
| Non-head and neck pathologists | 190 (58.5%) |